⭐️⭐️⭐️⭐️⭐️ "A total no brainer"

⭐️⭐️⭐️⭐️⭐️ "Love this, so easy."

Spots is the easy way to track your skin, mole and cancer changes.

Spots Global Cancer Trial Database for Vincristine, Dactinomycin, and Cyclophosphamide in Treating Patients With Embryonal Rhabdomyosarcoma

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Trial Identification

Brief Title: Vincristine, Dactinomycin, and Cyclophosphamide in Treating Patients With Embryonal Rhabdomyosarcoma

Official Title: Phase II Trial of VAC2.2/VA Therapy for Low-Risk B Group Patients With Rhabdomyosarcoma

Study ID: NCT00245089

Conditions

Sarcoma

Study Description

Brief Summary: RATIONALE: Drugs used in chemotherapy, such as vincristine, dactinomycin, and cyclophosphamide, work in different ways to stop the growth of tumor cells, either by killing the cells or by stopping them from dividing. Giving more than one drug (combination chemotherapy) may kill more tumor cells. PURPOSE: This phase II trial is studying how well giving vincristine, dactinomycin, and cyclophosphamide together works in treating patients with embryonal rhabdomyosarcoma.

Detailed Description: OBJECTIVES: * Determine the progression-free survival rate in patients with low-risk embryonal rhabdomyosarcoma treated with intensive chemotherapy comprising vincristine, dactinomycin, and cyclophosphamide followed by vincristine and dactinomycin. OUTLINE: Patients receive vincristine IV, dactinomycin IV, and cyclophosphamide IV on day 1. Treatment repeats every 21 days for 8 courses in the absence of disease progression or unacceptable toxicity. Patients then receive vincristine IV and dactinomycin IV on day 1. Treatment repeats every 3 weeks for 8 courses in the absence of disease progression or unacceptable toxicity. PROJECTED ACCRUAL: A total of 41 patients will be accrued for this study.

Eligibility

Minimum Age:

Eligible Ages: CHILD

Sex: ALL

Healthy Volunteers: No

Locations

Anjo Kosei Hosptial, Anjo, Aichi, Japan

Aichi Medical University, Nagakuti, Aichi, Japan

National Hospital Orgnization Nagoya Medical Center, Nagoya, Aichi, Japan

Ehime Prefectural Central Hospital, Matsuyama-shi, Ehime, Japan

National Kyushu Cancer Center, Fukuoka-shi, Fukuoka, Japan

Kurume University School of Medicine, Kurume City, Fukuoka, Japan

Gifu Municipal Hospital, Gifu-shi, Gifu, Japan

Gunma Children's Medical Center, Seta-gun, Gunma, Japan

National Hospital Organization - Medical Center of Kure, Kure, Hiroshima, Japan

Sapporo Medical University, Sapporo, Hokkaido, Japan

Hokkaido University Graduate School of Medicine, Sapporo, Hokkaido, Japan

Kobe City General Hospital, Kobe, Hyogo, Japan

Ibaraki Children's Hospital, Mito-shi, Ibaraki, Japan

University of Tsukuba, Tsukuba-city, Ibaraki, Japan

Ishikawa Prefectural Central Hospital, Kanazawa-shi, Ishikawa, Japan

Kanazawa Medical University, Kanazawa, Ishikawa, Japan

Kagoshima City Hospital, Kagoshima City, Kagoshima, Japan

National Center for Child Health and Development, Tokyo, Kanagawa, Japan

Showa University Fujigaoka Hospital, Yokohama-shi, Kanagawa, Japan

Yokohama City University, Yokohama, Kanagawa, Japan

Miyazaki Medical College University of Miyazaki, Miyazaki-gun, Miyazaki, Japan

Nagano Children's Hospital, Toyoshina-machi, Nagano, Japan

Osaka Medical Center and Research Institute for Maternal and Child Health, Izumi, Osaka, Japan

Osaka City General Hospital, Suita-shi, Osaka, Japan

Osaka University Graduate School of Medicine, Suita-shi, Osaka, Japan

Osaka Medical College, Takatsuki City, Osaka, Japan

Dokkyo University School of Medicine, Koshigaya, Saitama, Japan

National Defense Medical College, Tokorozawa, Saitama, Japan

Shiga University of Medical Science, Otsu-shi, Shiga, Japan

Shimane University Hospital, Izumo, Shimane, Japan

Seirei Hamamatsu General Hospital, Hamamatsu, Shizuoka, Japan

Fukushima Medical University Hospital, Fukushima, , Japan

Gifu University Graduate School of Medicine, Gifu, , Japan

Hiroshima University Hospital, Hiroshima, , Japan

Kagoshima University, Kagoshima, , Japan

Kyoto Prefectural University of Medicine, Kyoto, , Japan

Kyoto University Hospital, Kyoto, , Japan

Osaka City University, Osaka, , Japan

Osaka General Medical Center, Osaka, , Japan

Saitama Children's Medical Center, Saitama, , Japan

Hokkaido Medical Center for Child Health and Rehabilitation, Sapporo, , Japan

National Cancer Center Hospital, Tokyo, , Japan

St. Luke's International Hospital, Tokyo, , Japan

Tokyo Medical and Dental University, Tokyo, , Japan

Toho University School of Medicine, Tokyo, , Japan

Keio University School of Medicine, Tokyo, , Japan

Nihon University Itabashi Hospital, Tokyo, , Japan

Yamagata University Hospital, Yamagata, , Japan

Contact Details

Name: Hajime Hosoi

Affiliation: Kyoto Prefectural University of Medicine

Role: STUDY_CHAIR

Name: Ryoji Hanada, MD

Affiliation: Saitama Children's Medical Center

Role:

Name: Keizo Horibe, MD, PhD

Affiliation: National Hospital Orgnization Nagoya Medical Center

Role:

Useful links and downloads for this trial

Clinicaltrials.gov

Google Search Results

Logo

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

spots app storespots app store

Join others from around the world: